Cargando…

Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide

Detalles Bibliográficos
Autor principal:	Thomsen, Henrik S.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2006
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1705479/ https://www.ncbi.nlm.nih.gov/pubmed/17061066 http://dx.doi.org/10.1007/s00330-006-0495-8

Ejemplares similares

Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents
por: Thomsen, Henrik S., et al.
Publicado: (2007)

Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
por: Elmholdt, Tina R., et al.
Publicado: (2013)

Nephrogenic systemic fibrosis
por: Braverman, Irwin M, et al.
Publicado: (2010)

Nephrogenic systemic fibrosis
por: Madke, Bhushan, et al.
Publicado: (2011)

Nephrogenic systemic fibrosis
por: Koratala, Abhilash, et al.
Publicado: (2017)

Understanding Nephrogenic Systemic Fibrosis
por: Chopra, Tushar, et al.
Publicado: (2012)

Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease
por: Bennett, Charles L., et al.
Publicado: (2012)

The Necessity of a Nationwide Surveillance System of Serious BCG Adverse Reactions
por: Cho, Hye-Kyung
Publicado: (2019)

NEPHROGENIC SYSTEMIC FIBROSIS: TIME FOR THE REQUIEM?
por: Panda, Saumya
Publicado: (2011)

NEPHROGENIC SYSTEMIC FIBROSIS: CURRENT CONCEPTS
por: Basak, Prasanta, et al.
Publicado: (2011)

Nephrogenic Systemic Fibrosis: Mini-Review
por: Mundim, Juliano Sacramento, et al.
Publicado: (2009)

NEPHROGENIC SYSTEMIC FIBROSIS: A BRIEF REVIEW
por: Waikhom, Rajesh, et al.
Publicado: (2011)

Nephrogenic systemic fibrosis: A frivolous entity
por: Bhargava, Vinant, et al.
Publicado: (2021)

Nephrogenic Systemic Fibrosis Risk and Liver Disease
por: Hanna, Robert F., et al.
Publicado: (2014)

Nephrogenic systemic fibrosis (NSF): the role of tamoxifen
por: Davison, Rachel, et al.
Publicado: (2010)

A moderate response to plasmapheresis in nephrogenic systemic fibrosis
por: Ustuner, Pelin, et al.
Publicado: (2011)

The fate of Gd and chelate following intravenous injection of gadodiamide in rats
por: Kindberg, Grete Mørk, et al.
Publicado: (2010)

A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions
por: Nevin, Remington L.
Publicado: (2017)

Gadolinium and nephrogenic systemic fibrosis: time to tighten practice
por: Mendichovszky, Iosif A., et al.
Publicado: (2007)

10 Years of Nephrogenic Systemic Fibrosis: A Comprehensive Analysis of Nephrogenic Systemic Fibrosis Reports Received by a Pharmaceutical Company from 2006 to 2016
por: Endrikat, Jan, et al.
Publicado: (2018)

Correction: Nephrogenic Systemic Fibrosis in Denmark– A Nationwide Investigation
Publicado: (2014)

Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis
por: Leung, Nelson, et al.
Publicado: (2009)

NEPHROGENIC SYSTEMIC FIBROSIS: REVIEW OF 408 BIOPSY-CONFIRMED CASES
por: Zou, Zhitong, et al.
Publicado: (2011)

Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance
por: Reiter, Theresa, et al.
Publicado: (2012)

Late Onset Nephrogenic Systemic Fibrosis in a Patient with Stage 3 Chronic Kidney Disease: a Case Report
por: Lim, Yu Jeong, et al.
Publicado: (2020)

Photopheresis Provides Significant Long-Lasting Benefit in Nephrogenic Systemic Fibrosis
por: Zhang, Ranran, et al.
Publicado: (2017)

Erythema nodosum masking nephrogenic systemic fibrosis as initial skin manifestation
por: Fuah, Kar Wah, et al.
Publicado: (2017)

Bilateral delayed endolymphatic hydrops evaluated by bilateral intratympanic injection of gadodiamide with 3T-MRI
por: Iwasa, Yoh-ichiro, et al.
Publicado: (2018)

Cochlear Lymph Fluid Signal Increase in Patients with Otosclerosis after Intravenous Administration of Gadodiamide
por: NAGANAWA, Shinji, et al.
Publicado: (2016)

New Oral Coaxial Nanofibers for Gadodiamide-Prospective Intestinal Magnetic Resonance Imaging and Theranostic
por: Darwesh, Alaa Yaser, et al.
Publicado: (2020)

Absence of human herpes virus-8 (HHV8) in nephrogenic systemic fibrosis
por: O'Donnell, Patrick J, et al.
Publicado: (2008)

The incidence of nephrogenic systemic fibrosis in subjects receiving gadoversetamide for cardiovascular magnetic resonance
por: Crowley, Anna Lisa, et al.
Publicado: (2012)

Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol
por: Elmholdt, Tina Rask, et al.
Publicado: (2010)

Prevalence and imaging features of nephrogenic systemic fibrosis at two large medical centers
por: Prince, Martin R, et al.
Publicado: (2009)

Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis
por: Bose, Chhanda, et al.
Publicado: (2015)

Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience
por: Grahn, Amy Y., et al.
Publicado: (2009)

Anterior pituitary gland T1 signal intensity is influenced by time delay after injection of gadodiamide
por: Mallio, Carlo A., et al.
Publicado: (2020)

Repeat and single dose administration of gadodiamide to rats to investigate concentration and location of gadolinium and the cell ultrastructure
por: Davies, Julie, et al.
Publicado: (2021)

Predicting serious rare adverse reactions of novel chemicals
por: Poleksic, Aleksandar, et al.
Publicado: (2018)

Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions
por: Bennett, Charles L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tm66jvvkev66n8vqdf3efo07rg